Here is some other vaccine news of note for the week:
> A petition challenging Merck's decision to phase out a RotaTeq supply deal for four African countries has generated nearly 50,000 signatures. Petition | FiercePharma article
> GeoVax signed a partnership with Virometix to develop a therapeutic HPV vaccine. Release
> Initial data for NantKwest's cancer vaccine left analysts confused about the candidate's potential benefit. FierceBiotech article
> ImmusanT started a phase 2 study for its celiac disease vaccine. Release (PDF)
> With support from the Gates Foundation, InDevR will apply its VaxArray potency testing platform to measles and rubella vaccines. Release